Physician profile
Aung Tun
NPI 1649252370
$3,849.99
in general payments reported to CMS, 2019-2025
34 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $592 · 2021: $723 · 2022: $384 · 2023: $245 · 2024: $596 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,714.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $569.20 | 2020-2025 | Amvia Edge, Pulsar-18 T3, Solia |
| Medtronic, INC. | $404.39 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Boston Scientific Corporation | $354.99 | 2019-2025 | Resonate El Icd Vr, Lux-Dx Insertable Cardiac Monitor, Momentum El Icd Vr |
| Novartis Pharmaceuticals Corporation | $289.88 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $182.08 | 2019-2023 | Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $179.78 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $172.39 | 2019-2024 | Xarelto |
| Pfizer INC. | $165.09 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $159.52 | 2021-2025 | Lifevest |
| Philips North America LLC | $134.55 | 2020-2024 | (Ck4) Mcot |
| Amarin Pharma, INC. | $124.26 | 2020-2022 | |
| Lundbeck LLC | $117.55 | 2019-2021 | |
| Alnylam Pharmaceuticals INC. | $114.90 | 2024-2025 | Onpattro |
| Edwards Lifesciences Corporation | $113.21 | 2019-2025 | Sapien 3 Ultra Resilia |
| Abbott Laboratories | $94.08 | 2019-2024 | Mitraclip, Jeti Peripheral Catheter |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $86.62 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $77.72 | 2019-2024 | Eliquis, Camzyos |
| Medtronic Vascular, INC. | $74.16 | 2019-2020 | |
| Glaxosmithkline, LLC. | $52.53 | 2025 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $41.84 | 2021-2024 | Verquvo |
| Siemens Medical Solutions USA, INC. | $34.09 | 2020 | |
| Stryker Corporation | $31.33 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $31.24 | 2019-2024 | Repatha |
| Inari Medical, INC. | $28.30 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Jubilant Draximage, INC. | $27.68 | 2025 | Technetium Tc 99m Sestamibi |
| Abiomed | $27.17 | 2022 | |
| Chiesi USA, INC. | $25.22 | 2019 | |
| Portola Pharmaceuticals, LLC | $24.17 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.44 | 2021 | |
| Becton, Dickinson and Company | $20.40 | 2024 | Venclose Maven Catheter |
| Elutia, INC. | $19.93 | 2023 | |
| Astellas Pharma US INC | $19.47 | 2019 | |
| Angiodynamics, INC. | $19.47 | 2024 | Venacure 1470 Pro |
| Kowa Pharmaceuticals America, INC. | $11.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aung Tun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.